Brad Spellberg
@bradspellberg.bsky.social
1.5K followers 37 following 270 posts
Posts Media Videos Starter Packs
bradspellberg.bsky.social
People told me it was too radical at my place too. But then we walked everyone through the policy, which was developed with Counsel and Risk input. It is an actual structured policy that creates a due process mechanism for doing the right thing. It turns out to be rational, rather than radical.
bradspellberg.bsky.social
The main take away is to implement a Policy to Override Policies at your institutions too.
bradspellberg.bsky.social
Yeah but you’re Lawful Good. That’s ok. We need Lawful people too. It’s all about balance, right?
bradspellberg.bsky.social
Thanks to @abimfoundation.bsky.social ation for posting the video of my recent lecture on the LA General Policy to Override Policies. For those of you who know my lectures, this one is among the most entertaining. And it's only 10 min. Check it out & implement the policy!
youtu.be/RuKAKH8A604?...
Administrator/Clinician Collaboration: Policies to Put Patients First
YouTube video by ABIM Foundation
youtu.be
Reposted by Brad Spellberg
jameswilsondo.bsky.social
Another plug for #wikiguidelines @bradspellberg.bsky.social
When guidelines don’t keep up with medicine
unmc-id.bsky.social
UNMC ID faculty Dr. Jenn Davis and 🌟 resident Dr. Gigi Green joined up to publish an interesting case in @cidjournal.bsky.social as part of the Clinical Delimmas in ID series:

"A Blurry Line: Navigating Treatment Decisions When the Guidelines Don't Fit"

#IDSky

academic.oup.com/cid/advance-...
A Blurry Line: Navigating Treatment Decisions When the Guidelines Don’t Fit
A 45-year-old female was referred to the infectious diseases (ID) clinic for interpretation of discordant human immunodeficiency virus (HIV) test results.
academic.oup.com
bradspellberg.bsky.social
I was thinking Samuel Clemens. “…lies, damn lies, and statistics.”
bradspellberg.bsky.social
It’s also an absurd conclusion based on wonky stats. A 48% chance dalba was superior? Seriously? How about, no chance. Based on both pre test prob and the actual clinical endpoint results.
Reposted by Brad Spellberg
sebpoule.bsky.social
I love Dalba
I just don’t know why we should do a PhD in statistics to understand a trial now
Or maybe am just getting old and grumpy
a white monkey with a blue face is sitting on a blue blanket .
ALT: a white monkey with a blue face is sitting on a blue blanket .
media.tenor.com
bradspellberg.bsky.social
#5/5 You have not actually prevented any infections. You simply suppressed colonization growth from non-sterile sites. We are clear in our Discussion that the studies found a statistical reduction in infections that was likely not a true reduction in infections. The trials were poorly designed.
bradspellberg.bsky.social
#4/5 When you randomized pts to receive abx or not, and then take cultures from non sterile sites, you will OBVIOUSLY grow more bacteria from the patients randomized to NOT receive abx. You are suppressing colonization with abx. This makes it appear that an infection was prevented. But...
bradspellberg.bsky.social
#3/4 The #2 infection type was "pneumonia". Again, numerous studies over the last 20 years have shown that a high percentage of "pneumonias" diagnosed in hospital are not actually pneumonias.
Which brings us the fundamental error in the design of all of these trials...
bradspellberg.bsky.social
#2/4 The #1 "infection" type in these RCTs was "UTI" based on positive urine culture, with no description of symptoms being present. Since we know that >50% of "UTIs" in hospitals are not UTIs, but asymptomatic bacteriuria, the majority of infections were not actually infections.
bradspellberg.bsky.social
#1/5 The problem is even worse than that. It's not simply a trade off of preventing infections vs. worsening resistance & adverse effects. Indeed, it is not at all clear that infections were actually prevented at all in these RCTs. As we discuss, the definition of infection was highly problematic.
Reposted by Brad Spellberg
Reposted by Brad Spellberg
idiots-pod.bsky.social
#IDsky The Infectious Disease Brad Boy himself, @bradspellberg.bsky.social , has an updated Oral vs IV table, now including the Plague (Y really) and Lyme!

Link here:

www.bradspellberg.com/oral-antibio...
Oral Antibiotic RCTs | mysite
www.bradspellberg.com
bradspellberg.bsky.social
Oooh i like that! The ID Brad Boy. But it was the OG Gangsta @idiots-pod.bsky.social that came up with this idea. So get on with yo’ bad self!
Reposted by Brad Spellberg
wiki-guidelines.bsky.social
WikiGuidelines lapel pins are available for purchase on
WikiGuidelines website: www.wikiguidelines.org
Support us to incorporate humility of uncertainty into guidelines!
bradspellberg.bsky.social
I tend to agree. Especially if a catheter is in place. But if a pt has signs/symptoms of infection, i do it.
bradspellberg.bsky.social
Q: Is [insert test name] test being over used?

A: Yes!
Reposted by Brad Spellberg
drrossanarosa.bsky.social
“We’re asking the wrong question. Let’s use fundamental PK. Let’s get the drug to where the bug is, at a high enough concentration to kill the bug, and not worry about whether we label the drug static or cidal”.
As said by @bradspellberg.bsky.social 🤩😇

Fabulous conversation!
#IDSky #MedSky #AMSSky
asm.org
ASM @asm.org · Jul 9
Bactericidal vs Bacteriostatic Antibiotics. This controversial topic has important conceptual ramifications to treat severe infections. youtu.be/3z4BItBrzbk
Bactericidal vs Bacteriostatic Antibiotics - Editors in Conversation Podcast, Live from ASM Microbe
YouTube video by American Society for Microbiology
youtu.be
bradspellberg.bsky.social
Imitation is the sincerest form of flattery, my good friends!
bradspellberg.bsky.social
Even more important for sicker patients!!!!